Grant: Engage Grants Program
Université de Montréal
$22,850.00
Optimization of screening procedures for monoclonal antibodies directed against membrane bound proteins
FY 2016-17
Summary
The generation of monoclonal antibodies (mAb), individual antibodies directed against a specific protein orregion of a protein, represent extremely valuable research tools. Because of the incredible specificity ofantibodies in recognize their target, researchers can use them to precisely identify the location or activity levelof individual proteins. This in turn allows basic biological processes such as gene expression, cell growth anddifferentiation and protein function to be better understood. Despite their value, the process of generating mAbis technically challenging and inefficient. In a typical procedure, hundreds or even thousands of individual cellsmust be checked in order to identify one or two which produce the correct type of antibodies. In addition,because of the way in which mAb are made, many of the cells that produce antibodies are unstable and stopgrowing, leading to the loss of that specific antibody. In this project, we will test a new method for screeningthe antibody producing cells at an earlier time point, in a high-throughput fashion, in order to more efficientlyidentify antibody producing cells of interest. In addition, we will test the use of a highly sensitive DNAsequencing technology that will allow us to capture the DNA sequence of the gene that makes the antibody ineach cell. As a result, if the antibody is identified as valuable but the cell stops growing, we can recreate thegene in another cell to recover the same antibody. If successful, this project will not only increase the efficiencyof antibody production, but it will also provide a new safeguard against the loss of valuable antibodies.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
506486-2016
Name nom
Wilhelm, Brian
Department département
Institut de recherche en immunologie et en cancérologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
22850
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Partie
1
Nb partie
1
Application title
Optimization of screening procedures for monoclonal antibodies directed against membrane bound proteins
Keyword
NSERC
Application summary
The generation of monoclonal antibodies (mAb), individual antibodies directed against a specific protein orregion of a protein, represent extremely valuable research tools. Because of the incredible specificity ofantibodies in recognize their target, researchers can use them to precisely identify the location or activity levelof individual proteins. This in turn allows basic biological processes such as gene expression, cell growth anddifferentiation and protein function to be better understood. Despite their value, the process of generating mAbis technically challenging and inefficient. In a typical procedure, hundreds or even thousands of individual cellsmust be checked in order to identify one or two which produce the correct type of antibodies. In addition,because of the way in which mAb are made, many of the cells that produce antibodies are unstable and stopgrowing, leading to the loss of that specific antibody. In this project, we will test a new method for screeningthe antibody producing cells at an earlier time point, in a high-throughput fashion, in order to more efficientlyidentify antibody producing cells of interest. In addition, we will test the use of a highly sensitive DNAsequencing technology that will allow us to capture the DNA sequence of the gene that makes the antibody ineach cell. As a result, if the antibody is identified as valuable but the cell stops growing, we can recreate thegene in another cell to recover the same antibody. If successful, this project will not only increase the efficiencyof antibody production, but it will also provide a new safeguard against the loss of valuable antibodies.